Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis
Annals of Internal Medicine: Clinical Cases · 01.06.2026 · 5 (6)
DOI: 10.7326/aimcc.2025.0551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine: Clinical Cases, erschienen am 01.06.2026. Verfasst von Silpa Mandava und 5 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mandava, S., Rynerson, D., Eng, N., Memon, R. A., Jamot, S., & Dy, G. K. (2026). Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis. Annals of Internal Medicine: Clinical Cases, 5(6). https://doi.org/10.7326/aimcc.2025.0551
Vancouver
Mandava S, Rynerson D, Eng N, Memon RA, Jamot S, Dy GK. Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis. Annals of Internal Medicine: Clinical Cases. 2026;5(6). doi:10.7326/aimcc.2025.0551
BibTeX
@article{Mandava2026,
author = {Mandava, Silpa and Rynerson, Deidre and Eng, Nicole and Memon, Raima A. and Jamot, Sehrish and Dy, Grace K.},
title = {Recurrent Diarrhea Induced by Immune Checkpoint Inhibitor Therapy: Importance of Endoscopic Evaluation to Identify Causes Other Than Acute Immune-Related Colitis},
journal = {Annals of Internal Medicine: Clinical Cases},
year = {2026},
volume = {5},
number = {6},
doi = {10.7326/aimcc.2025.0551}
}
EUVIMED